Javascript must be enabled to continue!
Effects of Bcg on Lymphocyte Trapping
View through CrossRef
Abstract
The effects of Bacillus-Calmette Guerin (BCG) administration upon lymphocyte traffic was studied in BALB/cJ mice. Intravenous or subcutaneous injection of BCG resulted in increased localization (trapping) of 51Cr-labeled syngeneic lymphocytes in the spleen or draining nodes. BCG-induced splenic trapping was biphasic, occurring 1 to 2 days after BCG injection, and reappearing 3 weeks later. Trapping in draining lymph nodes persisted and increased during the 24 days of study. These results are in contrast to those obtained with SRBC, where trapping was evident only within the first few days of antigen injection.
Additional studies revealed that prior injection of BCG influenced the ensuing magnitude of SRBC-induced trapping. Intravenous administration of BCG suppressed SRBC-induced splenic trapping; both intravenous and subcutaneous injection of BCG enhanced trapping to SRBC in the draining lymph nodes.
These studies suggest that one mechanism for potentiation of immune responses by BCG may operate via BCG's effects upon regulation of lymphocyte traffic to the lymphoid tissues.
Title: Effects of Bcg on Lymphocyte Trapping
Description:
Abstract
The effects of Bacillus-Calmette Guerin (BCG) administration upon lymphocyte traffic was studied in BALB/cJ mice.
Intravenous or subcutaneous injection of BCG resulted in increased localization (trapping) of 51Cr-labeled syngeneic lymphocytes in the spleen or draining nodes.
BCG-induced splenic trapping was biphasic, occurring 1 to 2 days after BCG injection, and reappearing 3 weeks later.
Trapping in draining lymph nodes persisted and increased during the 24 days of study.
These results are in contrast to those obtained with SRBC, where trapping was evident only within the first few days of antigen injection.
Additional studies revealed that prior injection of BCG influenced the ensuing magnitude of SRBC-induced trapping.
Intravenous administration of BCG suppressed SRBC-induced splenic trapping; both intravenous and subcutaneous injection of BCG enhanced trapping to SRBC in the draining lymph nodes.
These studies suggest that one mechanism for potentiation of immune responses by BCG may operate via BCG's effects upon regulation of lymphocyte traffic to the lymphoid tissues.
Related Results
BCG induced neutrophil extracellular traps formation and its regulatory mechanism
BCG induced neutrophil extracellular traps formation and its regulatory mechanism
Abstract
Background Intravesical BCG is one of the most effective immunotherapies for bladder cancer. Our previous study showed that BCG could induce the formation of neutr...
BCG induced neutrophil extracellular traps formation and its regulatory mechanism
BCG induced neutrophil extracellular traps formation and its regulatory mechanism
Abstract
Background Intravesical BCG is one of the most effective immunotherapies for bladder cancer. Our previous study showed that BCG induces the formation of neutrophil...
BCG-induced neutrophil extracellular traps formation and its regulatory mechanism
BCG-induced neutrophil extracellular traps formation and its regulatory mechanism
Abstract
Background: Intravesical BCG is one of the most effective immunotherapies for bladder cancer. Our previous study showed that BCG induces the formation of neutrophi...
BCG and Alternative Therapies to BCG Therapy for Non-Muscle-Invasive Bladder Cancer
BCG and Alternative Therapies to BCG Therapy for Non-Muscle-Invasive Bladder Cancer
Bladder cancer is a heterogeneous disease. Treatment decisions are mostly decided based on disease stage (non-muscle invasive or muscle invasive). Patients with muscle-invasive dis...
Correlation between immunity from BCG and the morbidity and mortality of COVID-19
Correlation between immunity from BCG and the morbidity and mortality of COVID-19
Abstract
Background To investigate the association between parameters indicating immunity from BCG at country level (presence of BCG vaccination policy, BCG coverage, age-s...
Correlation between immunity from BCG and the morbidity and mortality of COVID-19
Correlation between immunity from BCG and the morbidity and mortality of COVID-19
Abstract
Background To investigate the association between parameters indicating immunity from BCG at country level (presence of BCG vaccination policy, BCG coverage, age-s...
Adverse effects and discontinuation of pembrolizumab in BCG refractory non-muscle invasive bladder cancer.
Adverse effects and discontinuation of pembrolizumab in BCG refractory non-muscle invasive bladder cancer.
588 Background: Non-muscle invasive bladder cancer (NMIBC) is associated with high rates of recurrence and progression despite adequate intravesical treatment with Bacillus Calmet...
Correlation between immunity from BCG and the morbidity and mortality of COVID-19
Correlation between immunity from BCG and the morbidity and mortality of COVID-19
Abstract
Purpose
To investigate the association between parameters indicating immunity from BCG at country level (presence of BCG vaccination policy, BCG coverage, age-spe...

